Health NewsFeed

Health Newsfeed

STATIN OR NOT?

ANCHOR LEAD: UNTIL GUIDELINES ARE MODIFIED, WHO SHOULD CONSIDER STATINS?  ELIZABETH TRACEY REPORTS

Using data from a very large cardiovascular disease study known as Jupiter, along with national data from an ongoing study called NHANES, Erin Michos, a cardiologist at Johns Hopkins, says many more people might benefit from statin therapy than previously thought.

MICHOS:  What I am doing now is if I have an older patient,  a man over the age of fifty, a woman over the age of sixty, if they do not currently meet indications for statins I might use C-reactive protein as a tie-breaker.  If it was elevated I might have a discussion with them about consideration of statin.  I  would give all of my patients of course a six month trial of lifestyle changes.  We know that exercise and weight loss both lower CRP so if the CRP was elevated I would first recommend the lifestyle changes.   :29

Michos says for those who don’t respond to exercise, diet and weight loss, a statin may well prove the most efficacious way to reduce cardiovascular disease risk.  At Johns Hopkins, I’m Elizabeth Tracey.


-- JHMI --
Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home